Skip to content
Open access

Post-traumatic headache: A two-arm parallel-group, randomized, single-blind, sham-controlled clinical superiority trial evaluating repetitive transcranial magnetic stimulation as a novel treatment modality.

Nov 2026 · Headache · 0 citations · 77 references
Medicine

TL;DR

High-frequency rTMS targeting the left DLPFC was associated with a statistically significant reduction in monthly moderate-to-severe headache days compared with sham in adults with pPTH 4-5 months post-trauma.

Abstract

Objective

This study aimed to evaluate the effect of repetitive transcranial magnetic stimulation (rTMS) on persistent post-traumatic headache (pPTH) in adults with pPTH and a high burden of persistent post-concussion symptoms (pPCS) 4-5 months after mild traumatic brain injury (mTBI).

Background

pPTH is a disabling sequela of mTBI with no established effective treatment. rTMS is a promising treatment modality.

Methods

This two-arm parallel-group, randomized (1:1), single-blind, sham-controlled, clinical superiority trial was conducted at Hammel Neurorehabilitation Centre and University Research Clinic, Hammel, Denmark from August 2023 to August 2024. Participants were randomized to receive five sessions of either active high-frequency rTMS (HF-rTMS; 2000 pulses, 10 Hz) or sham stimulation targeting the left dorsolateral prefrontal cortex (DLPFC) 4-5 months post-trauma. The primary outcome was the monthly mean difference in change in headache days of moderate-to-severe intensity between the active treatment group and the sham group. This was assessed using daily headache diaries before and after intervention. Secondary outcomes included measures of pPCS burden and headache impact, and pain catastrophizing at 1- and 3-month follow-up.

Results

A total of 62 participants were randomized (rTMS, n = 30; sham, n = 32). In the intention-to-treat (ITT) population (n = 62), the adjusted monthly mean difference in change (i.e., the treatment effect) between the active treatment group and the sham group was -1.55 (95% confidence interval [CI]: [-3.10; -0.01], p = 0.049) headache days. The treatment effect in a sensitivity analysis of the modified ITT population (n = 61) was -1.08 (95% CI: [-2.60; 0.45]), p = 0.166) headache days. No significant adjusted mean difference in change was observed for any secondary outcome between the active rTMS group and the sham group from baseline to 1 month end of treatment (EOT): it was -0.58 (95% CI: [-1.23; 0.08], p = 0.084) for headache intensity on the Numerical Rating Scale; 0.14 days (95% CI: [-1.01; 1.29], p = 0.816) for acute medication use; -4.07 (95% CI: [-8.81; 0.69], p = 0.093) for total Rivermead Post-Concussion Symptoms Questionnaire score; -1.08 (95% CI: [-4.80; 2.64], p = 0.567) for Headache Impact Test score; -1.36 (95% CI: [-2.91; 0.19], p = 0.085) for Symptom Checklist-6 subscale depression score; 1.74 (95% CI: [-5.22; 1.73], p = 0.324) for Pain Catastrophizing Scale score. The primary outcome and all secondary outcomes, except acute medication use, showed significant reductions over time in both groups (p < 0.001).

Conclusion

High-frequency rTMS targeting the left DLPFC was associated with a statistically significant reduction in monthly moderate-to-severe headache days compared with sham in adults with pPTH 4-5 months post-trauma; however, the sensitivity analysis did not support the findings. Both groups demonstrated symptom reduction over time, likely reflecting spontaneous recovery and non-specific treatment effects. Further studies are needed to confirm these findings and to further evaluate the role of rTMC in pPTH, including alternative stimulation targets and treatment protocols.

Read PDF

Similar papers

Oct 2026

A Series of N-of-1 Trials Characterizing Individual Responses to Theta-Burst Stimulation in Post-traumatic Trigeminal Neuropathic Pain.

Post-traumatic trigeminal neuropathic pain (PTNP) is challenging to treat, as conventional therapies have limited efficacy and side-effects, requiring individualized management. N-of-1 trials focus on individualized/personalized medicine. Theta burst stimulation (TBS), a modified form of high-frequency repetitive trans...

Mohit Kothari, Nicole Renner, Anupriyadarshini Devendran et al. · 0 citations
Nov 2026

Efficacy of Repetitive Transcranial Magnetic Stimulation in Preventing Poststroke Spasticity: A Sham-Controlled Trial.

BACKGROUND Poststroke spasticity significantly impairs recovery, yet preventive strategies remain limited. This study evaluated the effectiveness of repetitive transcranial magnetic stimulation (rTMS) in reducing the development and severity of spasticity in patients with early subacute stroke, offering a possible earl...

Venkata Divya Mupparaju, S. Bhoi, Menka Jha et al. · 0 citations
Open access Nov 2026

Clinical Outcomes and Corticomotor Excitability After Accelerated High-Frequency rTMS in Refractory Trigeminal Neuralgia: A Prospective Comparative Cohort Study

Objective: The objective of this study is to evaluate three-month changes in corticomotor excitability, assessed by motor-evoked potential (MEP) amplitudes, following accelerated high-frequency repetitive transcranial magnetic stimulation (rTMS) of the primary motor cortex (M1) in patients with refractory trigeminal ne...

Polya Ivanova Lambeva, P. Bozhinov, P. Tonchev et al. · 0 citations
Oct 2026

Multi-center, randomized controlled efficacy and comparative-effectiveness study evaluating ketamine, stellate ganglion blocks, combination treatment, and sham treatments for posttraumatic stress disorder and traumatic brain injury-associated headache: a study protocol.

BACKGROUND Posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI) are conditions that share common mechanisms and are highly co-prevalent with each other and chronic pain. This pragmatic study will compare ketamine infusions to stellate ganglion blocks (SGB), their combination, and a placebo-sham-control...

Steven P. Cohen, Roman Smolynets, Jordan Wood et al. · 0 citations
Open access Sep 2026

Brain photobiomodulation therapy for acute sport-related concussion: a randomized, single-blinded, pilot clinical trial (RECOVERY study)

Background The current standard of care for concussion relies on symptom management; there are almost no disease-modifying treatments. The RECOVERY study investigated the safety of RGn550 (REGEnLIFE), a novel neurostimulation device combining brain photobiomodulation with a static magnetic field, in sportspeople with a...

Jean-François Chermann, P. Malafosse, Guillaume Champleboux et al. · 0 citations
Open access Oct 2026

High-Intensity Transcranial Alternating Current Stimulation for Post-Stroke Cognitive Impairment: A Triple-Blind Randomized Trial.

Hi-tACS improved global cognition and working memory in patients with PSCI and was generally well tolerated, and as a broad-network stimulation approach may reduce reliance on selecting a single precise target, a potential practical advantage in heterogeneous PSCI.

Yi-Nan Ai, Shu-Xian Zhang, Li Huang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.